SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-067966
Filing Date
2024-03-14
Accepted
2024-03-14 16:37:00
Documents
14
Period of Report
2024-03-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788095d8k.htm   iXBRL 8-K 46287
  Complete submission text file 0001193125-24-067966.txt   179350

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grph-20240314.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20240314_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20240314_pre.xml EX-101.PRE 12157
15 EXTRACTED XBRL INSTANCE DOCUMENT d788095d8k_htm.xml XML 3875
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 24750808
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)